SurgePays (NASDAQ:SURG – Free Report) had its price objective lowered by Ascendiant Capital Markets from $9.00 to $8.50 in a research note issued to investors on Monday morning,Benzinga reports. The brokerage currently has a buy rating on the medical equipment provider’s stock.
SurgePays Stock Performance
Shares of SurgePays stock opened at $1.72 on Monday. SurgePays has a 12 month low of $1.33 and a 12 month high of $9.23. The company has a quick ratio of 4.70, a current ratio of 6.24 and a debt-to-equity ratio of 0.08. The stock has a market cap of $34.68 million, a PE ratio of -1.52 and a beta of 1.01. The business has a fifty day simple moving average of $1.76 and a 200-day simple moving average of $2.27.
SurgePays (NASDAQ:SURG – Get Free Report) last posted its earnings results on Tuesday, November 12th. The medical equipment provider reported ($0.73) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.22) by ($0.51). The business had revenue of $4.77 million during the quarter, compared to analyst estimates of $8.64 million. SurgePays had a negative net margin of 27.39% and a negative return on equity of 55.63%. During the same quarter last year, the firm earned $0.49 earnings per share. On average, sell-side analysts anticipate that SurgePays will post -1.34 EPS for the current fiscal year.
Insiders Place Their Bets
Institutional Investors Weigh In On SurgePays
Institutional investors have recently made changes to their positions in the stock. Virtu Financial LLC acquired a new stake in SurgePays during the 3rd quarter worth $25,000. Renaissance Technologies LLC bought a new position in shares of SurgePays during the 2nd quarter valued at about $45,000. Royce & Associates LP bought a new position in shares of SurgePays during the 3rd quarter valued at about $34,000. Dimensional Fund Advisors LP grew its position in shares of SurgePays by 49.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 24,331 shares of the medical equipment provider’s stock valued at $78,000 after purchasing an additional 7,998 shares during the period. Finally, Corsair Capital Management L.P. increased its stake in SurgePays by 50.3% during the 3rd quarter. Corsair Capital Management L.P. now owns 29,864 shares of the medical equipment provider’s stock worth $55,000 after purchasing an additional 10,000 shares in the last quarter. 6.94% of the stock is owned by institutional investors and hedge funds.
About SurgePays
SurgePays, Inc, together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities.
Read More
- Five stocks we like better than SurgePays
- What is the S&P/TSX Index?
- Semtech Stock Climbs as AI Boom Drives Turnaround Success
- Dividend Payout Ratio Calculator
- 3 Companies Leading the Way With Aggressive Stock Buybacks
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Is It Time to Buy Nuclear Energy Stocks After the Latest Dip?
Receive News & Ratings for SurgePays Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SurgePays and related companies with MarketBeat.com's FREE daily email newsletter.